SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (3391)12/18/2002 3:54:10 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 10345
 
>> GlycoGenesys, Inc. Reclassifies Series A Preferred Stock <<

8-K filed today, according to Dow Jones...... GlycoGenesys JV ends. Rights to GCS-100 revert to GG, with Elan retaining a royalty right. $1.9M in R&D reimbursement to GG, Elan gets series A and B preferred shares.